Assessing Arthur J. Gallagher (AJG) Valuation As Long Term Gains Contrast With Recent Share Price Weakness

Arthur J. Gallagher & Co. +0.59%

Arthur J. Gallagher & Co.

AJG

217.61

+0.59%

Event context and what has investors looking at Arthur J. Gallagher (AJG)

With no single headline event driving attention today, interest in Arthur J. Gallagher (AJG) centers on how its current share price of $256.15 lines up with recent returns and the company’s underlying insurance brokerage and risk management business.

Recent trading has been choppy, with a 1 day share price return of 0.32% decline and a 90 day share price return of 8.67% decline. The 5 year total shareholder return of 126.83% contrasts with the 1 year total shareholder return of 12.64% decline, which may indicate that long term momentum has eased.

If this kind of insurance broker has your attention, it can be useful to compare it with other financial names. You can also widen your view by scanning fast growing stocks with high insider ownership.

So with revenue and net income both growing at around 19% and 21% a year, an intrinsic value estimate suggesting a 27% discount, and a share price near $256, is Arthur J. Gallagher a genuine opportunity, or is the market already pricing in that growth?

Most Popular Narrative: 15% Undervalued

With Arthur J. Gallagher last closing at US$256.15 against a narrative fair value estimate of about US$301.28, the current price sits below that implied level, which puts the focus squarely on how future growth and margins are being modeled.

Analysts expect earnings to reach $3.5 billion (and earnings per share of $13.46) by about September 2028, up from $1.6 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $4.2 billion in earnings, and the most bearish expecting $2.9 billion.

This raises the question of what justifies that kind of earnings step up while still assuming a lower P/E than today. The entire narrative leans on ambitious revenue growth, wider margins and a premium earnings multiple that sits above the broader insurance group. The exact mix of those inputs is doing the heavy lifting.

Result: Fair Value of $301.28 (UNDERVALUED)

However, that fair value story could easily be challenged if softness in property rates weighs on commissions, or if the acquisition-heavy model runs into integration or regulatory issues.

Another Angle On Valuation

Those fair value narratives paint Arthur J. Gallagher as 15% to 26% undervalued, yet the current P/E of 41.2x stands well above the US Insurance industry at 12.7x, peers at 22.8x, and our fair ratio of 18.9x. This raises the question of whether the story here is potential upside or valuation risk if sentiment cools.

NYSE:AJG P/E Ratio as at Jan 2026
NYSE:AJG P/E Ratio as at Jan 2026

Build Your Own Arthur J. Gallagher Narrative

If you see the numbers differently, or simply prefer to work through the data yourself, you can build a custom view in minutes with Do it your way.

A great starting point for your Arthur J. Gallagher research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Arthur J. Gallagher has sharpened your thinking, do not stop here. Use the same structured approach to scan wider markets and pressure test your next moves.

  • Spot potential value opportunities by sifting through these 870 undervalued stocks based on cash flows that may trade below what their cash flows imply.
  • Ride major technology shifts by zeroing in on these 24 AI penny stocks that are tied to artificial intelligence themes.
  • Tap into income focused ideas by reviewing these 12 dividend stocks with yields > 3% that might complement or balance your existing positions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.